Women’s motivations for participating in the dapivirine vaginal ring open label extension study

References

• Almeida, L., Azevedo, B., Nunes, T., Vaz-da-Silva, M., & Soares-da-Silva, P. (2007). Why healthy subjects volunteer for phase I studies and how they perceive their participation? European Journal of Clinical Pharmacology, 63(11), 1085–1094. https://doi.org/10.1007/s00228-007-0368-3
   PubMed Web of Science ®Google Scholar
• Atieno, S. (2022, June 13). Hiv: Africa gearing towards deployment of vaginal ring. Science Africa. https://scienceafrica.co.ke/2022/06/13/hiv-africa-gearing-towards-deployment-of-vaginal-ring/.
   Google Scholar
• Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., Siva, S., Bekker, L.-G., Jeenarain, N., Gaffoor, Z., Martinson, F., Makanani, B., Pather, A., Naidoo, L., Husnik, M., … Hillier, S. (2016). Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New England Journal of Medicine, 375(22), 2121–2132. https://doi.org/10.1056/NEJMoa1506110
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Palanee-Phillips, T., Mgodi, N. M., Mayo, A. J., Szydlo, D. W., Ramjee, G., Gati Mirembe, B., Mhlanga, F., Hunidzarira, P., Mansoor, L. E., Siva, S., Govender, V., Makanani, B., Naidoo, L., Singh, N., Nair, G., Chinula, L., Parikh, U. M., Mellors, J. W., … Brown, E. R.., MTN-025/HOPE Study Team (2021). Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet. HIV, 8(2), e87–e95. https://doi.org/10.1016/S2352-3018(20)30304-0
   PubMed Web of Science ®Google Scholar
• Bentley, J. P., & Thacker, P. G. (2004). The influence of risk and monetary payment on the research participation decision making process. Journal of Medical Ethics, 30(3), 293–298. https://doi.org/10.1136/jme.2002.001594
   PubMed Web of Science ®Google Scholar
• Colfax, G., Buchbinder, S., Vamshidar, G., Celum, C., McKirnan, D., Neidig, J., Koblin, B., Gurwith, M., & Bartholow, B. (2005). Motivations for participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes (1999), 39(3), 359–364. https://doi.org/10.1097/01.qai.0000152039.88422.ec
   PubMed Web of Science ®Google Scholar
• Dainesi, S. M., & Goldbaum, M. (2011). Provision of investigational drug after clinical research: review of literature, national and international guidelines. Revista da Associacao Medica Brasileira (1992), 57(6), 710–716. https://doi.org/10.1590/S0104-42302011000600021
   PubMed Web of Science ®Google Scholar
• Dhalla, S., & Poole, G. (2011). Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. AIDS Care, 23(11), 1430–1447. https://doi.org/10.1080/09540121.2011.555750
   PubMed Web of Science ®Google Scholar
• Dubé, K., Perry, K. E., Mathur, K., Lo, M., Javadi, S. S., Patel, H., Concha-Garcia, S., Taylor, J., Kaytes, A., Dee, L., Campbell, D., Kanazawa, J., Smith, D., Gianella, S., Auerbach, J. D., Saberi, P., & Sauceda, J. A. (2020). Altruism: Scoping review of the literature and future directions for HIV cure-related research. Journal of Virus Eradication, 6(4), 100008. https://doi.org/10.1016/j.jve.2020.100008
   PubMed Web of Science ®Google Scholar
• Emanuel, E. J., Currie, X. E., Herman, A., & Phidisa, P. (2005). Undue inducement in clinical research in developing countries: is it a worry? Lancet (London, England), 366(9482), 336–340. https://doi.org/10.1016/S0140-6736(05)66992-9
   PubMed Web of Science ®Google Scholar
• Fokazi S. (2022, March 16). More HIV prevention options for SA women as vaginal ring is approved. Timeslive. https://www.timeslive.co.za/news/south-africa/2022-03-16-more-hiv-prevention-options-for-sa-women-as-vaginal-ring-approved/
   Google Scholar
• Gold, O. P., & John, E. U. (2013). Accelerating empowerment for sustainable development: The need for health systems strengthening in Sub-Saharan Africa. American Journal of Public Health Research, 1(7), 152–158. https://doi.org/10.12691/ajphr-1-7-2
   Google Scholar
• Haire, B. G., & Ogundokun, O. (2014). Ethics of ancillary care in clinical trials in low income countries: a Nigerian case study. African Journal of Reproductive Health, 18(3 Spec No), 135–142.
   PubMed Web of Science ®Google Scholar
• Halpern, S. D., Karlawish, J. H., Casarett, D., Berlin, J. A., & Asch, D. A. (2004). Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Archives of Internal Medicine, 164(7), 801–803. https://doi.org/10.1001/archinte.164.7.801
   PubMedGoogle Scholar
• Hlongwa, M., Peltzer, K., & Hlongwana, K. (2020). Risky sexual behaviours among women of reproductive age in a high HIV burdened township in KwaZulu-Natal, South Africa. BMC Infectious Diseases, 20(1), 1–9. https://doi.org/10.1186/s12879-020-05302-1
   Web of Science ®Google Scholar
• Katz, A., Mensch, B. S., Woeber, K., Musara, P., Etima, J., & van der Straten, A. (2019). Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence. BMC Women's Health, 19(1), 18. https://doi.org/10.1186/s12905-019-0713-6
   PubMedGoogle Scholar
• Mash, R., Mash, B., & de Villiers, P. (2010). ‘Why don’t you just use a condom?’: Understanding the motivational tensions in the minds of South African women. African Journal of Primary Health Care & Family Medicine, 2(1), 4. https://doi.org/10.4102/phcfm.v2i1.79
   Google Scholar
• Mfutso-Bengo, J., Ndebele, P., Jumbe, V., Mkunthi, M., Masiye, F., Molyneux, S., & Molyneux, M. (2008). Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi. Malawi Medical Journal: The Journal of Medical Association of Malawi, 20(2), 37–41. https://doi.org/10.4314/mmj.v20i2.10898
   PubMed Web of Science ®Google Scholar
• Mngadi, K. T., Frohlich, J., Montague, C., Singh, J., Nkomonde, N., Mvandaba, N., Ntombeka, F., Luthuli, L., Abdool Karim, Q., & Mansoor, L. (2015). Challenges with participant reimbursement: experiences from a post-trial access study. Journal of Medical Ethics, 41(11), 909–913. https://doi.org/10.1136/medethics-2013-101899
   PubMed Web of Science ®Google Scholar
• Mngadi, K. T., Singh, J. A., Mansoor, L. E., & Wassenaar, D. R. (2017). Undue inducement: a case study in CAPRISA 008. Journal of Medical Ethics, 43(12), 824–828. https://doi.org/10.1136/medethics-2016-103414
   PubMed Web of Science ®Google Scholar
• Montgomery, E. T., Katz, A., Duby, Z., Mansoor, L. E., Morar, N. S., Naidoo, K., Tsidya, M., Chitukuta, M., Guma, V., Tenza, S., Leslie, J., Garcia, M., & Naidoo, S. (2021). Men's sexual experiences with the dapivirine vaginal ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS and Behavior, 25(6), 1890–1900. https://doi.org/10.1007/s10461-020-03119-2
   PubMed Web of Science ®Google Scholar
• Montgomery, E. T., Stadler, J., Naidoo, S., Katz, A., Laborde, N., Garcia, M., Reddy, K., Mansoor, L. E., Etima, J., Zimba, C., Chitukuta, M., & Soto-Torres, L. (2018). Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS (London, England), 32(11), 1517–1525. https://doi.org/10.1097/QAD.0000000000001868
   PubMed Web of Science ®Google Scholar
• Naidoo, K., Mansoor, L. E., Katz, A., Garcia, M., Kemigisha, D., Morar, N. S., Zimba, C. C., Chitukuta, M., Reddy, K., Soto-Torres, L., Naidoo, S., & Montgomery, E. T. (2021). Qualitative perceptions of dapivirine VR adherence and drug level feedback following an open-label extension trial. Journal of Acquired Immune Deficiency Syndromes (1999), 86(4), e90–e96. https://doi.org/10.1097/QAI.0000000000002590
   PubMed Web of Science ®Google Scholar
• Nel, A., van Niekerk, N., Kapiga, S., Bekker, L. G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., Miti, N., Kusemererwa, S., Tempelman, H., Carstens, H., Devlin, B., Isaacs, M., Malherbe, M., Mans, W., Nuttall, J., … Rosenberg, Z., Ring Study Team (2016). Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. New England Journal of Medicine, 375(22), 2133–2143. https://doi.org/10.1056/NEJMoa1602046
   PubMed Web of Science ®Google Scholar
• Nel, A., van Niekerk, N., Van Baelen, B., Malherbe, M., Mans, W., Carter, A., Steytler, J., van der Ryst, E., Craig, C., Louw, C., Gwetu, T., Mabude, Z., Kotze, P., Moraba, R., Tempelman, H., Gill, K., Kusemererwa, S., Bekker, L. G., Devlin, B., & Rosenberg, Z., DREAM Study Team (2021). Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV, 8(2), e77–e86. https://doi.org/10.1016/S2352-3018(20)30300-3
   PubMed Web of Science ®Google Scholar
• Psaros, C., Milford, C., Smit, J. A., Greener, L., Mosery, N., Matthews, L. T., Harrison, A., Gordon, J. R., Mimiaga, M., Bangsberg, D. R., & Safren, S. A. (2018). Hiv prevention Among young women in South Africa: Understanding multiple layers of risk. Archives of Sexual Behavior, 47(7), 1969–1982. https://doi.org/10.1007/s10508-017-1056-8
   PubMed Web of Science ®Google Scholar
• Sullivan, K., Mtande, T., Jaffe, E., Rosenberg, N., Zimba, C., Hoffman, I., Little, M., Faden, R., & Lyerly, A. D. (2020). Views among Malawian women about joining HIV prevention clinical trials when pregnant. AIDS Research and Therapy, 17(1), 27. https://doi.org/10.1186/s12981-020-00271-6
   PubMed Web of Science ®Google Scholar
• UNAIDS Data. (2021). Geneva: Joint United Nations Programme on HIV/AIDS. https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf.
   Google Scholar
• Warren, E. A., Paterson, P., Schulz, W. S., Lees, S., Eakle, R., Stadler, J., & Larson, H. J. (2018). Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review. PloS one, 13(6), e0198680. https://doi.org/10.1371/journal.pone.0198680
   PubMed Web of Science ®Google Scholar